Skip to main content

Study identifies risk factors for RMD flares following COVID-19 vaccination

Research from the COVID-19 Global Rheumatology Alliance has identified a number of factors, including diagnosis and vaccine type, that are associated with flare risk following vaccination among people with rheumatic and musculoskeletal diseases.


ABC–DO shows poor breast cancer treatment compliance in sub-Saharan Africa

A high proportion of women with nonmetastatic breast cancer in sub-Saharan Africa do not initiate or complete treatment, show data from the African Breast Cancer–Disparities in Outcomes prospective cohort.

Headlines from across medwireNews

20-05-2022 | Oncology | News | Article

First-line tiragolumab–atezolizumab promising for PD-L1-positive advanced NSCLC

Previously untreated patients with PD-L1-positive advanced non-small-cell lung cancer could benefit from the combination of tiragolumab plus atezolizumab, indicate phase 2 trial data.

20-05-2022 | Rheumatology | News | Article

EULAR issues guidance on telemedicine in rheumatology

EULAR has put forward “points to consider” that aim to guide the integration of telehealth into rheumatology clinical practice.

20-05-2022 | Diabetes | News | Article

Survival time analysis shows CV benefits of GLP1 receptor agonists

Glucagon-like peptide-1 receptor agonists may delay the incidence of major adverse cardiovascular events by an average of 0.6 months over a 4-year period in people with type 2 diabetes, meta-analysis data suggest.

20-05-2022 | Oncology | News | Article

QoL and OS benefits linked in cancer treatment trials

Around a quarter of phase 3 randomized controlled trials for advanced cancer show an improvement in global quality of life and this is significantly linked to improvements in overall survival, Canadian researchers say.

19-05-2022 | Diabetes | News | Article

Semaglutide offers alternative to prandial insulin in type 2 diabetes

Adding a weekly semaglutide injection in people already using basal insulin to treat type 2 diabetes avoids the need for prandial insulin, show the SUSTAIN 11 findings.

19-05-2022 | Oncology | News | Article

ASCO releases guideline on lifestyle changes during cancer treatment

Find out more about the recommendations on exercise, diet, and weight management here

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team